We have located links that may give you full text access.
Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope.
American Journal of Cardiology 1984 April 2
The effectiveness of an open referral electrocardiographic monitoring service in identifying an arrhythmogenic cause for syncope was evaluated. Over 5 years, 7,364 patients of all ages underwent ambulatory 24-hour electrocardiographic (Holter) monitoring using a 2-channel recorder. Of these, 1,512 (20.5%) were referred because of syncope. During monitoring, 15 patients had syncope and 7 of the episodes were related to an arrhythmia, usually ventricular tachycardia. Presyncope was reported in 241 patients, with a related arrhythmia in 24. Thus, an arrhythmia-related symptom that could be diagnostic was present in only 2% of the patients monitored. However, syncope or presyncope without an associated arrhythmia might be considered a negative diagnostic clue and occurred in 225 (15%). High-grade atrioventricular block was present in 15 and ventricular tachycardia in 116; only 6 (5%) reported associated symptoms. An age-related incremental increase in atrial and ventricular arrhythmias was found. In 415 of the 1,004 patients (41%) aged 60 years or more, arrhythmias that are conventionally associated with sinoatrial disease were recorded. Using stringent diagnostic criteria, the sick sinus or tachybradycardia syndrome was present in 33 (3%). Many older patients (70%) were taking drugs that could be arrhythmogenic, hypotensive or both. It is concluded that an open referral 24-hour ambulatory monitoring service rarely results in identifying relevant symptom-related arrhythmias in patients with syncope. It records many asymptomatic arrhythmias that can compound rather than resolve the diagnostic problem in older patients, because the data obtained could lead to unnecessary therapy. An iatrogenic cause for syncope should always be considered.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app